Postpartum Smoking Relapse Prevention by Breastfeeding Promotion
2 other identifiers
interventional
60
1 country
1
Brief Summary
This is a randomized controlled trial to prevent postpartum smoking relapse by breastfeeding promotion. The intervention group (N=30) will receive multicomponent breastfeeding intervention from late pregnancy to 6 months postpartum, while the attention placebo control group (N=30) will receive general infant care counseling and support. The key outcome is the rate of postpartum smoking relapse.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 31, 2018
CompletedFirst Submitted
Initial submission to the registry
December 10, 2020
CompletedFirst Posted
Study publicly available on registry
December 17, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedResults Posted
Study results publicly available
May 15, 2025
CompletedMay 15, 2025
May 1, 2025
5.4 years
December 10, 2020
April 28, 2025
May 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants Reporting to Breastfeed
During postpartum, mothers report their breastfeeding status (exclusive, mixed with formula, non-breastfeeding) every month until 9 months postpartum. Any breastfeeding is defined as exclusive breastfeeding or mixed-feeding breast milk and formula.
9 months postpartum
Study Arms (2)
Breastfeeding intervention group
EXPERIMENTALA multicomponent behavioral intervention to promote breastfeeding
Attention placebo control group
PLACEBO COMPARATORGeneral infant care counseling and support
Interventions
The intervention group will receive multicomponent interventions consisting of 7 half-hour postnatal visits for lactation counseling, family/peer/employer support, contingent financial incentives, and early limited formula milk via syringe (optional for at-risk infants).
The attention placebo control group will complete the same frequency and duration of study visits as the intervention group but focus on general infant care counseling and support.
Eligibility Criteria
You may qualify if:
- Be pregnant or in the first 1 month postpartum
- Be 18 years or older
- Have quit smoking cigarettes during or before this pregnancy
- Be willing to receive infant care and breastfeeding education
- Be able to read, listen, and talk in English
You may not qualify if:
- Medical conditions contraindicating breastfeeding such as HIV infection, active tuberculosis, and breast removal
- Current heavy drinking (more than 2 drinks a day)
- Current use of illicit substances
- Being strongly against breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Division of Behavioral Medicine Department of Pediatrics Jacobs School of Medicine and Biomedical Sciences State University of New York at Buffalo
Buffalo, New York, 14214, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Xiaozhong Wen
- Organization
- State University of New York at Buffalo
Study Officials
- PRINCIPAL INVESTIGATOR
Xiaozhong Wen
State University of New York at Buffalo
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 10, 2020
First Posted
December 17, 2020
Study Start
July 31, 2018
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
May 15, 2025
Results First Posted
May 15, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share